Article metrics
PDF
Other content recommended for you
- Should rare diseases get special treatment?
- Establishing cost-effectiveness threshold in China: a community survey of willingness to pay for a healthy life year
- Solidarity, justice and unconditional access to healthcare
- A framework for luck egalitarianism in health and healthcare
- Rare neurological diseases: a practical approach to management
- FDA approval, clinical trial evidence, efficacy, epidemiology, and price for non-orphan and ultra-rare, rare, and common orphan cancer drug indications: cross sectional analysis
- Distributive justice and the harm to medical professionals fighting epidemics
- How the past matters for the future: a luck egalitarian sustainability principle for healthcare resource allocation
- A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug Regulation
- Industry funding of patient organisations in the UK: a retrospective study of commercial determinants, funding concentration and disease prevalence